W1RB34 Stock Overview
W. R. Berkley Corporation, an insurance holding company, operates as a commercial lines writers worldwide.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
W. R. Berkley Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$33.94 |
52 Week High | US$36.60 |
52 Week Low | US$27.81 |
Beta | 0.57 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | 17.49% |
5 Year Change | n/a |
Change since IPO | 46.52% |
Recent News & Updates
Recent updates
Shareholder Returns
W1RB34 | BR Insurance | BR Market | |
---|---|---|---|
7D | 0% | -0.7% | -0.5% |
1Y | n/a | 26.1% | 17.7% |
Return vs Industry: Insufficient data to determine how W1RB34 performed against the BR Insurance industry.
Return vs Market: Insufficient data to determine how W1RB34 performed against the BR Market.
Price Volatility
W1RB34 volatility | |
---|---|
W1RB34 Average Weekly Movement | n/a |
Insurance Industry Average Movement | 4.3% |
Market Average Movement | 4.7% |
10% most volatile stocks in BR Market | 8.1% |
10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: W1RB34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine W1RB34's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1967 | 8,329 | Rob Berkley | https://www.berkley.com |
W. R. Berkley Corporation, an insurance holding company, operates as a commercial lines writers worldwide. It operates in two segments, Insurance and Reinsurance & Monoline Excess. The Insurance segment underwrites commercial insurance business, including excess and surplus lines, admitted lines, and specialty personal lines.
W. R. Berkley Corporation Fundamentals Summary
W1RB34 fundamental statistics | |
---|---|
Market cap | R$110.72b |
Earnings (TTM) | R$6.87b |
Revenue (TTM) | R$60.43b |
16.1x
P/E Ratio1.8x
P/S RatioIs W1RB34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
W1RB34 income statement (TTM) | |
---|---|
Revenue | US$12.14b |
Cost of Revenue | US$6.90b |
Gross Profit | US$5.25b |
Other Expenses | US$3.86b |
Earnings | US$1.38b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 5.38 |
Gross Margin | 43.20% |
Net Profit Margin | 11.38% |
Debt/Equity Ratio | 38.0% |
How did W1RB34 perform over the long term?
See historical performance and comparison